S-Dodecyl (S)-4-(4-(1H-1,2,3-triazol-1-yl)benzamido)-5-(4-methylpiperazin-1-yl)-5-oxopentanethioate

Catalog No. :
ACECBL648
CAS No. :
1990505-78-6
Molecular Formula :
C31H48N6O3S
Molecular Weight :
584.83

IUPAC Name:S-dodecyl (S)-4-(4-(1H-1,2,3-triazol-1-yl)benzamido)-5-(4-methylpiperazin-1-yl)-5-oxopentanethioate

S-Dodecyl (S)-4-(4-(1H-1,2,3-triazol-1-yl)benzamido)-5-(4-methylpiperazin-1-yl)-5-oxopentanethioate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameS-Dodecyl (S)-4-(4-(1H-1,2,3-triazol-1-yl)benzamido)-5-(4-methylpiperazin-1-yl)-5-oxopentanethioate
IUPAC NameS-dodecyl (S)-4-(4-(1H-1,2,3-triazol-1-yl)benzamido)-5-(4-methylpiperazin-1-yl)-5-oxopentanethioate
Molecular FormulaC31H48N6O3S
Molecular Weight584.83
SMILESO=C(SCCCCCCCCCCCC)CC[C@H](NC(C1=CC=C(N2N=NC=C2)C=C1)=O)C(N3CCN(C)CC3)=O
InChI KeyFSSJOKCTBNZGQB-NDEPHWFRSA-N
Synonym1-Piperazinepentanethioic acid, 4-methyl-δ-oxo-γ-[[4-(1H-1,2,3-triazol-1-yl)benzoyl]amino]-, S-dodecyl ester, (γS)-;1-Piperazinepentanethioic acid, 4-methyl-δ-oxo-γ-[[4-(1H-1,2,3-triazol-1-yl)benzoyl]amino]-, S-dodecyl ester, (γS)-
CAS No.1990505-78-6

Synthetic Route by SureRoute

1. ACECBL648 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  4. Then
  5. ACECBL648 route product structure diagram
    ACECBL6481990505-78-6
Inquiry

2. ACECBL648 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXHMV569 route compound structure diagram
    ACXHMV569216959-87-4 In Stock
  4. Then
  5. ACECBL648 route product structure diagram
    ACECBL6481990505-78-6
Inquiry

Comments (0)